Conversio Health employs a comprehensive approach to managing chronic respiratory conditions such as COPD and asthma through innovative technologies and personalized care solutions. Central to their offering is the development of custom nebulizer medications, which enhance drug delivery and improve patient adherence. The company also utilizes smart portable devices, including Bluetooth-enabled nebulizers and inhaler sensors, which monitor medication usage and lung function in real-time. This integration of technology not only facilitates better medication management but also empowers patients to take control of their health through tools like the Conversio Connect app, which aggregates data and streamlines communication with healthcare providers.

In addition to these technological advancements, Conversio Health emphasizes a value-based care model that includes a dedicated team of clinical pharmacists, respiratory therapists, and health coaches. This team engages with patients regularly to provide tailored support, including medication therapy adjustments, health education, and smoking cessation programs. Their Inspire™ Virtual Pulmonary Rehabilitation Program further enhances patient outcomes by offering personalized exercise and education plans designed to improve lung function and overall quality of life. By leveraging AI and predictive analytics, Conversio Health identifies high-risk patients and delivers actionable insights to healthcare teams, ultimately aiming to reduce hospitalizations and lower the total cost of care for individuals with chronic respiratory diseases.

United States

Conversio Health is an innovative chronic condition management company focused on COPD and Asthma Disease Management. They aim to improve outcomes, prevent hospitalizations, and reduce the total cost of care for chronic respiratory conditions.

Conversio Health

Company Details